Cover Image

Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants

The present study explores the efficacy of plant-derived natural products (PDNPs) against spike glycoproteins (S-glycoprotein) of SARS-CoV-2 variants using molecular docking, ADMET, molecular dynamics (MD) simulation and density-functional theory (DFT) analysis. In all, 100 PDNPs were screened again...

Full description

Saved in:

Bibliographic Details
Main Authors:	Waseem Ahmad Ansari (Author), Mohd Aamish Khan (Author), Fahmina Rizvi (Author), Kajim Ali (Author), Mohd Kamil Hussain (Author), Mohammad Saquib (Author), Mohammad Faheem Khan (Author)
Format:	Book
Published:	MDPI AG, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Plant-Derived Metal Nanoparticles (PDMNPs): Synthesis, Characterization, and Oxidative Stress-Mediated Therapeutic Actions
by: Mohammad Faheem Khan, et al.
Published: (2023)

An ultrasound assisted, ionic liquid-molecular iodine synergy driven efficient green synthesis of pyrrolobenzodiazepine-triazole hybrids as potential anticancer agents
by: Mohammad Saquib, et al.
Published: (2023)

Natural product-inspired synthesis of coumarin-chalcone hybrids as potential anti-breast cancer agents
by: Nabil A. Alhakamy, et al.
Published: (2023)

Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants
by: Nur Dini Fatini Mohammad Faizal, et al.
Published: (2023)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
by: Zhouman He, et al.
Published: (2023)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
by: Anita M. Shete, et al.
Published: (2022)

Dietary Polyphenols, Plant Metabolites, and Allergic Disorders: A Comprehensive Review
by: Mohd Farhan, et al.
Published: (2024)

SAR-CoV-2 infection, emerging new variants and the role of activation induced cytidine deaminase (AID) in lasting immunity
by: Asad Ullah, et al.
Published: (2021)

Decoding the next SARS-CoV-2 variant
by: Jeremy Nel, et al.
Published: (2022)

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
by: Md. Aminul Islam, et al.
Published: (2023)

Analysis of C-reactive protein level in SARS-CoV-2 patients and its role in predicting the severity of SARS-CoV-2 infection
by: Rozina Arshi Khan, et al.
Published: (2023)

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
by: Bo-Seong Jeong, et al.
Published: (2022)

Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants
by: Riadh Badraoui, et al.
Published: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022)

The Emergence and Spread of Novel SARS-CoV-2 Variants
by: Huaimin Yi, et al.
Published: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

Investigating the Antiviral Properties of <i>Nyctanthes arbor-tristis</i> Linn against the Ebola, SARS-CoV-2, Nipah, and Chikungunya Viruses: A Computational Simulation Study
by: Raed Albiheyri, et al.
Published: (2024)

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
by: Kuldeep Dhama, et al.
Published: (2023)

Novel β-Coronavirus (SARS-CoV-2): Current and future aspects of pharmacological treatments
by: Nidhi Tiwari, et al.
Published: (2020)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

SARS-COV-2 Notable Mutations and Variants: A Review Article
by: Dariush Farhud, et al.
Published: (2022)

Different SARS-CoV-2 variants, same prevention strategies
by: Tafadzwa Dzinamarira, et al.
Published: (2022)

Screening for inhibitors against SARS-CoV-2 and its variants
by: Weijing Yuan, et al.
Published: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

Genetic variants of SARS-CoV-2 and its clinical implications
by: Alexander Expósito Lara, et al.
Published: (2021)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022)

Critically ill infants with SARS-COV-2 delta variant infection
by: Aida Borgi, et al.
Published: (2023)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023)

Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System
by: Ziad Tareq Naman, et al.
Published: (2022)

Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic
by: Smaranika Rahman, et al.
Published: (2022)

Cytokine Response in SARS-CoV-2 Infection in the Elderly
by: Sherwani S, et al.
Published: (2020)

A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries
by: Syed Umair Ahmad, et al.
Published: (2022)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitors
by: Maria Nuria Peralta-Moreno, et al.
Published: (2023)

A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
by: Laura Peyton Ellis, et al.
Published: (2023)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

In vitro study on efficacy of SKF7®, a Malaysian medicinal plant product against SARS-CoV-2
by: Mohd Ridzuan Mohd Abd Razak, et al.
Published: (2024)